BANCO MACRO SA-ADR (BMA)
US05961W1053 - ADR
BMA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 406 industry peers in the Banks industry. BMA may be in some trouble as it scores bad on both profitability and health. BMA shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
BMA had positive earnings in each of the past 5 years.
In multiple years BMA reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of BMA (5.16%) is better than 99.75% of its industry peers.
The Return On Equity of BMA (18.93%) is better than 96.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.16% | ||
| ROE | 18.93% | ||
| ROIC | N/A |
ROA(3y)4.51%
ROA(5y)4.21%
ROE(3y)16.17%
ROE(5y)16.7%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BMA's Profit Margin of 12.84% is on the low side compared to the rest of the industry. BMA is outperformed by 79.21% of its industry peers.
In the last couple of years the Profit Margin of BMA has declined.
BMA does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | 12.84% | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y5.35%
PM growth 5Y-6.18%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
Compared to 1 year ago, BMA has about the same amount of shares outstanding.
BMA has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BMA is higher compared to a year ago.
2.2 Solvency
A Debt/Equity ratio of 0.14 indicates that BMA is not too dependend on debt financing.
BMA's Debt to Equity ratio of 0.14 is fine compared to the rest of the industry. BMA outperforms 65.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | N/A | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
BMA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 415.48%, which is quite impressive.
The Earnings Per Share has been growing by 102.57% on average over the past years. This is a very strong growth
BMA shows a strong growth in Revenue. In the last year, the Revenue has grown by 296.55%.
Measured over the past years, BMA shows a very strong growth in Revenue. The Revenue has been growing by 119.85% on average per year.
EPS 1Y (TTM)415.48%
EPS 3Y170.06%
EPS 5Y102.57%
EPS Q2Q%524.11%
Revenue 1Y (TTM)296.55%
Revenue growth 3Y139.02%
Revenue growth 5Y119.85%
Sales Q2Q%-24.94%
3.2 Future
The Earnings Per Share is expected to grow by 28.94% on average over the next years. This is a very strong growth
Based on estimates for the next years, BMA will show a very strong growth in Revenue. The Revenue will grow by 65.50% on average per year.
EPS Next Y6.26%
EPS Next 2Y2.16%
EPS Next 3Y28.94%
EPS Next 5YN/A
Revenue Next Year311.2%
Revenue Next 2Y70.77%
Revenue Next 3Y65.5%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
BMA's earnings are expected to grow with 28.94% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.16%
EPS Next 3Y28.94%
5. Dividend
5.1 Amount
No dividends for BMA!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BANCO MACRO SA-ADR
NYSE:BMA (12/20/2024, 8:04:00 PM)
After market: 96.7 0 (0%)96.7
+1.46 (+1.53%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)
Earnings (Next)
Inst Owners5.03%
Inst Owner Change14.15%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap6.18B
Analysts72.73
Price Target56.28 (-41.8%)
Short Float %0.14%
Short Ratio1.91
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DP42.46%
Div Incr Years2
Div Non Decr Years2
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)237.45%
Min EPS beat(2)226.62%
Max EPS beat(2)248.28%
EPS beat(4)3
Avg EPS beat(4)653.97%
Min EPS beat(4)-71.05%
Max EPS beat(4)2212.03%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)39.3%
Min Revenue beat(2)-52.51%
Max Revenue beat(2)131.11%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)49.2%
EPS NQ rev (3m)49.2%
EPS NY rev (1m)0%
EPS NY rev (3m)-22.83%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)22.2%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)N/A
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpSN/A
BVpSN/A
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.16% | ||
| ROE | 18.93% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | 12.84% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)4.51%
ROA(5y)4.21%
ROE(3y)16.17%
ROE(5y)16.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y5.35%
PM growth 5Y-6.18%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.4
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 2.02% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)3.38%
Cap/Sales(5y)3.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)415.48%
EPS 3Y170.06%
EPS 5Y102.57%
EPS Q2Q%524.11%
EPS Next Y6.26%
EPS Next 2Y2.16%
EPS Next 3Y28.94%
EPS Next 5YN/A
Revenue 1Y (TTM)296.55%
Revenue growth 3Y139.02%
Revenue growth 5Y119.85%
Sales Q2Q%-24.94%
Revenue Next Year311.2%
Revenue Next 2Y70.77%
Revenue Next 3Y65.5%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-14888.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-43593.1%
OCF growth 3YN/A
OCF growth 5YN/A